Bavarian Nordic AS (CHIX:BAVAC) Other Current Liabilities: kr299 Mil (As of Mar. 2026)


CHIX:BAVAC Bavarian Nordic AS CHIX:BAVAC
84 GF Score
Price kr188.30
GF Value kr163.41
Valuation Modestly Overvalued
! 3 Warning Signs
View Full Analysis

What is Bavarian Nordic AS Other Current Liabilities?

Bavarian Nordic AS CHIX:BAVAC 84 Other Current Liabilities is kr299 Mil as of Mar. 2026. GuruFocus rates CHIX:BAVAC with a GF Score™ of 84/100 and a GF Value™ of kr163.41 (Modestly Overvalued). The stock has 3 warning signs investors should review.

Bavarian Nordic AS's other current liabilities for the quarter that ended in Mar. 2026 was kr299 Mil.

Bavarian Nordic AS's quarterly other current liabilities declined from Sep. 2025 (kr339 Mil) to Dec. 2025 (kr294 Mil) but then increased from Dec. 2025 (kr294 Mil) to Mar. 2026 (kr299 Mil).

Bavarian Nordic AS's annual other current liabilities declined from Dec. 2023 (kr1,568 Mil) to Dec. 2024 (kr1,468 Mil) and declined from Dec. 2024 (kr1,468 Mil) to Dec. 2025 (kr294 Mil).

Bavarian Nordic AS Other Current Liabilities Related Terms

Bavarian Nordic AS Other Current Liabilities Historical Data

* Premium members only.

The historical data trend for Bavarian Nordic AS's Other Current Liabilities can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Bavarian Nordic AS Other Current Liabilities Chart

Bavarian Nordic AS Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Other Current Liabilities
Get a 7-Day Free Trial Premium Member Only Premium Member Only 677.07 426.84 1,567.85 1,467.59 294.07

Bavarian Nordic AS Quarterly Data
Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
Other Current Liabilities Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 1,116.84 293.34 339.02 294.07 299.04
CHIX:BAVAC
84GF Score
Bavarian Nordic AS CHIX:BAVAC
Other Current Liabilities is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Bavarian Nordic AS Other Current Liabilities Calculation

The liability a company needs to pay in the next 12 months, but not assigned to Accounts Payable or Debt. For instance, Wal-Mart (WMT) has accrued wages, salaries, valuation, bonuses, insurance liabilities, accrued tax etc. These are all included in other current liabilities.

What does a Other Current Liabilities of kr299 Mil mean?
Bavarian Nordic AS (CHIX:BAVAC) has a Other Current Liabilities of kr299 Mil as of Mar. 2026. Other current liabilities as record on a company's balance sheet not categorized as standard liabilities. View historical data on Bavarian Nordic AS.
Is Bavarian Nordic AS's Other Current Liabilities too high?
Bavarian Nordic AS's current Other Current Liabilities is kr299 Mil. Overall, Bavarian Nordic AS has a GF Score™ of 84/100 and is considered Modestly Overvalued, reflecting its overall financial health beyond just this single metric.
How does Bavarian Nordic AS's Other Current Liabilities compare to VRTX and REGN?
Bavarian Nordic AS's Other Current Liabilities of kr299 Mil can be compared against companies in the Biotechnology industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Other Current Liabilities for a Biotechnology company?
A good Other Current Liabilities depends on the Biotechnology industry context. However, Other Current Liabilities should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Other Current Liabilities mean?
A high Other Current Liabilities can signal that a stock is expensive relative to its fundamentals. Other current liabilities as record on a company's balance sheet not categorized as standard liabilities. View historical data on Bavarian Nordic AS. Bavarian Nordic AS's current Other Current Liabilities is kr299 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Bavarian Nordic AS stock overvalued right now?
Based on GuruFocus' analysis, Bavarian Nordic AS (CHIX:BAVAC) is currently considered Modestly Overvalued. The stock's GF Value™ is kr163.41, compared to a current price of kr188.30 — trading 15.2% above its estimated fair value. The current Other Current Liabilities is kr299 Mil. Bavarian Nordic AS's overall GF Score™ is 84/100 with 3 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Other Current Liabilities calculated?
Other Current Liabilities is calculated from a company's financial statements. For Bavarian Nordic AS (CHIX:BAVAC), the current Other Current Liabilities is kr299 Mil as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Bavarian Nordic AS (CHIX:BAVAC) Overvalued in 2026?

Based on GuruFocus' analysis, Bavarian Nordic AS stock appears to be overvalued. The current stock price of kr188.30 is trading 15.2% above its estimated GF Value™ of kr163.41. GuruFocus considers Bavarian Nordic AS to be Modestly Overvalued.

Key valuation signals for CHIX:BAVAC:

  • Other Current Liabilities: kr299 Mil
  • GF Value™: kr163.41 vs. price of kr188.30 (15.2% above fair value)
  • GF Score™: 84/100 with 3 warning signs

No single metric tells the full story. See the CHIX:BAVAC stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Bavarian Nordic AS Business Description

Address Philip Heymans Alle 3, Hellerup, DNK, 2900
Bavarian Nordic AS is a biotechnology company focused on the research, development, manufacturing, and commercialization of life-saving vaccines. The group is a supplier of mpox and smallpox vaccines to governments to enhance public health preparedness and has a portfolio of travel vaccines. The vast majority of the company's revenue is generated in the United States, Germany, and other geographic markets. Its products include Encepur, Jynneos, Rabipur, Vaxchora, VIMKUNYA and Vivotif.
84GF Score

Get the complete analysis for CHIX:BAVAC

Other Current Liabilities is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

kr188.30
Price
kr163.41
GF Value